<DOC>
	<DOCNO>NCT02515526</DOCNO>
	<brief_summary>Protocol title : Effect acute alcohol consumption activity major cytochrome P450 enzymes , NAT2 P-glycoprotein . Objectives : The study mainly conduct evaluate effect acute alcohol consumption activity important drug metabolise cytochrome P450 enzymes CYP1A2 , CYP2C9 , CYP2C19 , CYP2D6 , intestinal CYP3A4 , hepatic CYP3A4 , NAT2 activity drug transporter p-glycoprotein ( intestinal renal ) . The study also provide basis plan clinical study interaction cause chronic alcohol intake . Design : Single center , open-label , two-way , cross-over study randomly allocate sequence Test-Reference Reference-Test . The study clinical drug study accord German Drug Act . Clinical phase : Not applicable Volunteers : 16 healthy male female subject plan completion accordance protocol , i.e . evaluable/analysable data period treatment . Clinical centre : Department Pharmacology , Clinical Pharmacology Unit ( KPH ) , University Cologne , Gleueler Str . 24 , 50931KÃ¶ln , Germany</brief_summary>
	<brief_title>Effect Acute Ethanol Consumption The Activity Major Cytochrome P450 Enzymes , NAT2 P-glycoprotein</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Tolbutamide</mesh_term>
	<criteria>Caucasian Age : 1855 year Normal body weight : ( body mass index 18.530 kg/m2 ) Considered healthy basis extensive prestudy screen Willing capable confirm write consent prior enrolment ample information provide . Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant ( `` clinically healthy '' ) . The inclusion criterion `` clinically healthy '' determine physical examination clinicalchemical test do prior clinical part study subject relevant clinical abnormality ( base extensive medical history , physical examination , vital sign 12lead ECG ) subject electrolyte disturbance subject cardiac arrhythmia subject history evidence hypertrophic obstructive cardiomyopathy subject history evidence stenosis gastrointestinal tract subject history evidence ulcerative colitis subject history evidence toxic mega colon subject history evidence myasthenia gravis subject evidence chronic infection subject history evidence bronchial asthma , COPD , pneumonia relevant respiratory disease subject acute infection within last two week subject history allergic disease clinical sign include hay fever drug allergy subject suspicion hypersensitivity investigational medication and/or subject history severe skin reaction subject clinically relevant laboratory abnormality ( incl . positive result hepatitis HIV serology ) subject receive medication within 1 week prior study start study ( exception possible upon decision Principal Investigator , e.g . paracetamol single dose acute pain topical acyclovir herpes labialis ) subject take drug long halflife ( &gt; 24 hour ) within four week first trial day subject receive chronic drug treatment ( &gt; 3 day ) within eight week first trial day subject participate trial novel investigational medication within last 8 week start present study subject participate trial register compound within last 4 week start present study subject donate blood plasma within last 4 week start present study actual smoker define subject smoke cigarette last three month subject know suspected ( social ) drug dependent , incl . drink 50 g alcohol per day , subject must reduce consumption 30 g. subject history alcohol recreational drug addiction subject positive drug screening test subject history severe disease might interfere study objective subject willing able abstain alcohol , give study medication Reference period , methylxanthinecontaining beverage food , caffeine contain product , papaver containing product grapefruit flesh / juice start 72 hour admission ward study post screening test subject adhere special diet ( e.g . vegetarian ) lifestyle ( incl . work night extreme physical activity competitive sport weight lift ) might interfere investigation subject plan elective hospital treatment within one month last intake trial medication subject know suspect comply study directives and/or know suspect reliable trustworthy subject know suspect capable understanding evaluate information give part formal information policy ( informed consent ) , particular regard foreseeable risk discomfort expose . Anticipated problem successfully place indwell venous catheter forearm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>